Robotic Assisted Sacral Colpopexy : A Prospective Study Assessing Outcomes With Learning Curves
NCT ID: NCT01535833
Last Updated: 2016-05-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2012-02-29
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Robotic-assisted Laparoscopic Sacrocolpopexy
NCT00581334
AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model.
NCT03764852
Uterosacral Ligament Suspension vs Robotic Sacrocolpopexy
NCT02741830
One Year Outcome After Robotic Assisted Laparoscopic Sacral Colpopexy, a Case Series Review
NCT01055860
Abdominal Colpopexy: Comparison of Endoscopic Surgical Strategies
NCT01124916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigators primary outcomes will be:
* Surgical time: Key portion of procedure will be assessed along with total time for completion
* Learning curve: Will be assessed using surgical times, VAS of camera skills, surgical skills involving tissue handling and movements and overall performance by surgeon, assistant and blind reviewer
* Length of hospitalization: measured by days in hopsital
The investigators secondary outcomes will be:
* Pre-operative and postoperative Pelvic Organ Prolapse-Quantification (POP-Q) at 6 week, 6, 12, and 24 months.
* Pelvic Floor Distress Inventory-Short Form 20 Questionnaire (PFDI-20)
* Mesh erosion,
* Estimated blood loss,
* Complications (bowel or bladder injury) and,
* Wound infection,
* Patient Global Impressions of Improvement
* Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Robotic sacral colpopexy
To assess subjects with stage 2 pelvic organ prolapse undergoing robotic sacral colpopex
Device- Robotic sacral colpopexy
To assess robotic sacral colpopexy for female patients with stage 2 pelvic organ prolapse
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Device- Robotic sacral colpopexy
To assess robotic sacral colpopexy for female patients with stage 2 pelvic organ prolapse
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Females only
* Undergoing robotic assisted laparoscopic sacrocolpopexy with or without other procedures for pelvic organ prolapse
* Willing to return for follow-up visits
* Written informed consent obtained from each subject
Exclusion Criteria
* Pregnant or contemplating future pregnancy (within a year)
* Unable to participate in the informed consent process
18 Years
80 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kaiser Permanente
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shawn A Menefee, MD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cynthia Brown
Role: STUDY_DIRECTOR
Southern California Kaiser permanente
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kaiser Permanente Downey
Los Angeles, California, United States
Kaiser Permanente San Diego
San Diego, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
John N Nguyen, MD
Role: primary
Gisselle Zazueta
Role: primary
Linda MacKinnon
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KP IRB 20111224
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.